Stock Research for CLSN

CLSN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CLSN Stock Chart & Research Data

The CLSN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CLSN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CLSN Due diligence Resources & Stock Charts

The CLSN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CLSN Detailed Price Forecast - CNN Money CNN View CLSN Detailed Summary - Google Finance
Yahoo View CLSN Detailed Summary - Yahoo! Finance Zacks View CLSN Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CLSN Trends & Analysis - Trade-Ideas Barrons View CLSN Major Holders - Barrons
NASDAQ View CLSN Call Transcripts - NASDAQ Seeking View CLSN Breaking News & Analysis - Seeking Alpha
Spotlight View CLSN Annual Report - CompanySpotlight.com OTC Report View CLSN OTC Short Report - OTCShortReport.com
TradeKing View CLSN Fundamentals - TradeKing Charts View CLSN SEC Filings - Bar Chart
WSJ View Historical Prices for CLSN - The WSJ Morningstar View Performance/Total Return for CLSN - Morningstar
MarketWatch View the Analyst Estimates for CLSN - MarketWatch CNBC View the Earnings History for CLSN - CNBC
StockMarketWatch View the CLSN Earnings - StockMarketWatch MacroAxis View CLSN Buy or Sell Recommendations - MacroAxis
Bullish View the CLSN Bullish Patterns - American Bulls Short Pains View CLSN Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CLSN Stock Mentions - StockTwits PennyStocks View CLSN Stock Mentions - PennyStockTweets
Twitter View CLSN Stock Mentions - Twitter Invest Hub View CLSN Investment Forum News - Investor Hub
Yahoo View CLSN Stock Mentions - Yahoo! Message Board Seeking Alpha View CLSN Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CLSN - SECform4.com Insider Cow View Insider Transactions for CLSN - Insider Cow
CNBC View CLSN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CLSN - OTC Markets
Yahoo View Insider Transactions for CLSN - Yahoo! Finance NASDAQ View Institutional Holdings for CLSN - NASDAQ


Stock Charts

FinViz View CLSN Stock Insight & Charts - FinViz.com StockCharts View CLSN Investment Charts - StockCharts.com
BarChart View CLSN Stock Overview & Charts - BarChart Trading View View CLSN User Generated Charts - Trading View


Latest Financial News for CLSN

Free Post Earnings Research Report: Egalet's Q4 Top-Line Growth Beat Estimates
Posted on Friday April 20, 2018

LONDON, UK / ACCESSWIRE / April 20, 2018 / Active-Investors.com has just released a free earnings report on Egalet Corp. (NASDAQ: EGLT). The Company posted its financial results on March 12, 2018, for the fourth quarter of the fiscal year 2017 (Q4 FY17) and for the full fiscal year 2017 (FY17). The Company's quarterly total revenues grew on a y-o-y basis to outshine market forecasts.


International Liver Congress™ 2018 Symposium Highlights Celsion’s ThermoDox® in Treatment of Primary Liver Cancer
Posted on Thursday April 12, 2018

LAWRENCEVILLE, N.J., April 12, 2018-- Celsion Corporation, an oncology drug development company, today announced a presentation and discussion of ThermoDox ®, its proprietary heat-activated liposomal encapsulation ...


Data Monitoring Committee (DMC) Completes Planned Safety and Data Review of Celsion’s Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
Posted on Monday April 09, 2018

Blinded Progression-Free Survival Rate in the OPTIMA Study is Consistent With the Subgroup Patient Population That Showed Benefit in the HEAT Study. ThermoDox ®- Highlighted Symposium,“ Emerging Horizons ...


Edited Transcript of CLSN earnings conference call or presentation 27-Mar-18 3:00pm GMT
Posted on Tuesday March 27, 2018

Q4 2017 Celsion Corp Earnings Call


Enter a stock symbol to view the stock details.